These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 18497067

  • 1. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP, Buteau-Lozano H, Herve MA, Corpet A.
    Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 3. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2007 May 01; 104(3-5):110-22. PubMed ID: 17478088
    [Abstract] [Full Text] [Related]

  • 4. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K, Banerjee S, Saxena N, Banerjee SK.
    Int J Oncol; 2003 Mar 01; 22(3):609-14. PubMed ID: 12579315
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
    van de Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, Seasholtz AF, van der Saag PT.
    Mol Endocrinol; 2004 Dec 01; 18(12):2908-23. PubMed ID: 15345745
    [Abstract] [Full Text] [Related]

  • 6. Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.
    Tonetti DA, Rubenstein R, DeLeon M, Zhao H, Pappas SG, Bentrem DJ, Chen B, Constantinou A, Craig Jordan V.
    J Steroid Biochem Mol Biol; 2003 Oct 01; 87(1):47-55. PubMed ID: 14630090
    [Abstract] [Full Text] [Related]

  • 7. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 01; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 8. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H, Murao K, Dobashi H, Bhuyan MM, Cao X, Kontani K, Niki S, Murazawa C, Nakajima H, Kohno N, Yamashita H, Iwase H, Hayashi S, Ishida T, Yamauchi A.
    Breast Cancer Res Treat; 2010 Jul 01; 122(2):395-407. PubMed ID: 19847644
    [Abstract] [Full Text] [Related]

  • 9. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M, Seger D, Kreizman T, Badikhi D, Margalit R, Eilam R, Degani H.
    Endocr Relat Cancer; 2009 Sep 01; 16(3):819-34. PubMed ID: 19398483
    [Abstract] [Full Text] [Related]

  • 10. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD, Mu YM, Lu XC, Xu ZM, Li XJ, Yu L, Song HJ, Li M, Lu JM, Zhao YL, Pan CY.
    Endocr Relat Cancer; 2003 Jun 01; 10(2):217-24. PubMed ID: 12790785
    [Abstract] [Full Text] [Related]

  • 11. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC, Schafer JM, Pearce ST, Osipo C, Chen B, Jordan VC.
    Gynecol Oncol; 2002 Jun 01; 85(3):498-506. PubMed ID: 12051881
    [Abstract] [Full Text] [Related]

  • 12. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA.
    Mol Endocrinol; 1999 Mar 01; 13(3):418-30. PubMed ID: 10076999
    [Abstract] [Full Text] [Related]

  • 13. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K, Thu N, Saville B, Safe S.
    Mol Endocrinol; 2003 May 01; 17(5):804-17. PubMed ID: 12576490
    [Abstract] [Full Text] [Related]

  • 14. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 01; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 15. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL.
    Mol Endocrinol; 2006 Dec 01; 20(12):3070-82. PubMed ID: 16901971
    [Abstract] [Full Text] [Related]

  • 16. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W, Jia M, Qin X, Hu J, Zhang X, Zhou G.
    FEBS J; 2013 Dec 01; 280(23):6128-40. PubMed ID: 24103091
    [Abstract] [Full Text] [Related]

  • 17. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
    Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S.
    Oncogene; 2004 Feb 05; 23(5):1052-63. PubMed ID: 14647449
    [Abstract] [Full Text] [Related]

  • 18. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2005 Feb 05; 94(1-3):71-81. PubMed ID: 15862952
    [Abstract] [Full Text] [Related]

  • 19. Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
    Wu J, Liang Y, Nawaz Z, Hyder SM.
    Int J Oncol; 2005 Dec 05; 27(6):1647-59. PubMed ID: 16273221
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
    Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Härkönen PL.
    Mol Cell Endocrinol; 1999 Mar 25; 149(1-2):29-40. PubMed ID: 10375015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.